Medimmune Oncology Drug Patent Portfolio
Medimmune Oncology owns 1 orange book drug protected by 1 US patent Given below is the list of Medimmune Oncology's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6017922 | Thermally stable trimetrexates and processes for producing the same | 18 May, 2018 | Expired |
Medimmune Oncology's Family Patents
Medimmune Oncology Drug List
Given below is the complete list of Medimmune Oncology's drugs and the patents protecting them.
1. Neutrexin
Neutrexin is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6017922 | Thermally stable trimetrexates and processes for producing the same |
18 May, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neutrexin's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List